TRT and Hair Loss: The DHT Mechanism, Who's Actually at Risk, and What Finasteride Does

TRT-associated hair loss is real, but it isn't a uniform side effect that hits every man who starts therapy — it's concentrated almost entirely in men who were already genetically predisposed to androgenetic alopecia, and the mechanism is specific enough that it's worth understanding before assuming TRT is the culprit for any hair change.

DHT, Not Testosterone Directly, Drives the Effect

Testosterone itself isn't the primary driver of androgenetic (pattern) hair loss — it's converted by the enzyme 5-alpha reductase into dihydrotestosterone (DHT), a more potent androgen that binds hair follicle receptors and, in genetically susceptible follicles, gradually shrinks them through a process called miniaturization. More circulating testosterone from TRT means more substrate available for conversion to DHT, which is the actual mechanistic link between TRT and accelerated hair thinning in predisposed individuals.

Why It's Not Universal

The genetic sensitivity of scalp hair follicles to DHT — largely governed by androgen receptor gene variants — is what determines whether a given man is vulnerable at all. Men without that genetic predisposition can have elevated testosterone and DHT without meaningful hair loss, while men with strong genetic susceptibility (a family history of male pattern baldness is the practical proxy most people use) are the ones who tend to notice accelerated thinning after starting TRT. This is the same reason not every man who has ever had normal or high natural testosterone goes bald — genetic follicle sensitivity, not testosterone level alone, is the deciding variable.

What Finasteride and Dutasteride Actually Do

Finasteride and dutasteride are 5-alpha reductase inhibitors — they block the enzyme responsible for converting testosterone to DHT, which is why they're used both for pattern hair loss on their own and sometimes co-administered with TRT specifically to blunt the DHT-driven hair loss risk. Finasteride selectively inhibits one isoform of the enzyme; dutasteride inhibits both isoforms more completely, producing a larger DHT reduction. The tradeoff is that reducing DHT reduces its other physiological roles too — libido and erectile function changes are a documented, if inconsistently experienced, side effect of 5-alpha reductase inhibitors, which is a real consideration when adding one to a TRT protocol whose whole purpose is often improving those same domains.

Topical Alternatives

Topical finasteride and topical minoxidil (which works through a different, non-hormonal vasodilatory mechanism) are sometimes used specifically to reduce the systemic DHT-suppression side effects associated with oral 5-alpha reductase inhibitors, while still targeting the scalp — an option some men on TRT explore precisely to avoid trading libido benefits for hair preservation.

Practical Takeaway

TRT accelerates hair loss primarily in men already genetically predisposed to it, via increased DHT conversion, not as a universal side effect of elevated testosterone. For men in that predisposed group who want to protect their hairline while on TRT, finasteride or dutasteride are mechanistically direct options, but they come with their own side-effect tradeoffs worth weighing against the very libido and sexual-function goals that often motivate starting TRT in the first place — a discussion for the prescribing physician, not a default add-on.